<p>Time to recurrence in patients in the adjuvant <sup>125</sup>I brachytherapy vs. in the control group, log-rank, <i>X</i><sup>2</sup> = 7.04, <i>p = </i>0.008.</p
<p>Logistic regression analysis for clinical variables predictive of recurrence as AT (analysis incl...
<p>Five-year rates by group: 44.8% no chemotherapy; 39.6% delay ≥8 weeks; 71.2% <8 weeks (p<0.001).<...
<p>When dealing with time to recurrence VDAC1 expression was again shown to be the most significant ...
<p>OS in patients in the adjuvant <sup>125</sup>I brachytherapy vs. in the control group, log-rank, ...
<p>Blue curve, patients whose physician used the MiCK assay. Red curve, patients whose physician did...
(A) Between the M1 and M2 groups, (B) between the M0 and M1 groups, and (C) between the M0 and M2 gr...
<p>Kaplan-Meier curves for median time to relapse (TTR) of radically resected colon cancer patients ...
<p>Receiver operating curve of short-term recurrence includes clinical variables as size (AUC = 0.58...
<p>Patients belonging to the low-MxA group (MxA <1.096) showed a significantly longer time to the ne...
<p>Distribution of the recurrence rate according to the time after resection, the higher rate of rec...
<p>The recurrence rate depended on the each treatment (Marasculio procedure).</p
<p>a. Recurrence-free survival curve for patients with pathologic T4 or T1-3 disease. b. Recurrence-...
<p>The population compositions at diagnosis (the time of initial treatment) and at the time of recur...
<p>Axes indicate logit-transformed proportions; inset scales indicate corresponding percentages. Sol...
<p><b>Time to relapse (A), Kaplan-Meier curve for RFS (B), and HR for disease recurrence (C) in the ...
<p>Logistic regression analysis for clinical variables predictive of recurrence as AT (analysis incl...
<p>Five-year rates by group: 44.8% no chemotherapy; 39.6% delay ≥8 weeks; 71.2% <8 weeks (p<0.001).<...
<p>When dealing with time to recurrence VDAC1 expression was again shown to be the most significant ...
<p>OS in patients in the adjuvant <sup>125</sup>I brachytherapy vs. in the control group, log-rank, ...
<p>Blue curve, patients whose physician used the MiCK assay. Red curve, patients whose physician did...
(A) Between the M1 and M2 groups, (B) between the M0 and M1 groups, and (C) between the M0 and M2 gr...
<p>Kaplan-Meier curves for median time to relapse (TTR) of radically resected colon cancer patients ...
<p>Receiver operating curve of short-term recurrence includes clinical variables as size (AUC = 0.58...
<p>Patients belonging to the low-MxA group (MxA <1.096) showed a significantly longer time to the ne...
<p>Distribution of the recurrence rate according to the time after resection, the higher rate of rec...
<p>The recurrence rate depended on the each treatment (Marasculio procedure).</p
<p>a. Recurrence-free survival curve for patients with pathologic T4 or T1-3 disease. b. Recurrence-...
<p>The population compositions at diagnosis (the time of initial treatment) and at the time of recur...
<p>Axes indicate logit-transformed proportions; inset scales indicate corresponding percentages. Sol...
<p><b>Time to relapse (A), Kaplan-Meier curve for RFS (B), and HR for disease recurrence (C) in the ...
<p>Logistic regression analysis for clinical variables predictive of recurrence as AT (analysis incl...
<p>Five-year rates by group: 44.8% no chemotherapy; 39.6% delay ≥8 weeks; 71.2% <8 weeks (p<0.001).<...
<p>When dealing with time to recurrence VDAC1 expression was again shown to be the most significant ...
DOI
Add to ORKG